About - CTRE :

CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.

Employees - 21, CEO - Mr. David M. Sedgwick, Sector - Real Estate, Country - US, Market Cap - 5.41B

Altman ZScore(max is 10): 6.68, Piotroski Score(max is 10): 5, Working Capital: $257555000, Total Assets: $3437016000, Retained Earnings: $0, EBIT: 192489000, Total Liabilities: $507633000, Revenue: $271541000

AryaFin Target Price - $34.5 - Current Price $28.85 - Analyst Target Price $31.62

Stats & Key Metrics
TickerCTRE
IndexRUT
Curent Price 28.85
Change1.05%
Market Cap5.41B
Average Volume1.80M
Income124.64M
Sales296.31M
Book Value/Share15.55
Cash/Share1.14
Dividend Est1.25 (4.33%)
Dividend TTM1.05 (3.66%)
Dividend Ex-DateMar 31, 2025
Employees21
Moving Avg 20days2.34%
Moving Avg 50days6.81%
Moving Avg 200days2.31%
Shares Outstanding186.99M
Earnings DateFeb 12 AMC
Inst. Ownership97.20%
Key Ratios & Margins
Price/Earnings36.86
Forwad P/E18.46
PE Growth1.34
Price/Sales18.27
Price/Book1.85
Price/Cash25.32
Price/FCF22.92
Quick Ratio-
Current Ratio-
Debt/Equity0.14
Return on Assets4.51%
Return on Equity5.76%
Return on Investment3.77%
Gross Margin76.24%
Ops Margin64.38%
Profit Margin42.06%
RSI61.74
BETA(β)0.91
From 52week Low24.71%
From 52week High-12.97%
Earnings & Valuation
EPS0.78
EPS next Year1.56
EPS next Qtr0.35
EPS this Year77.99%
EPS next 5 Year27.43%
EPS past 5 Year10.17%
Sales past 5 Year13.21%
EPS Y/Y61.55%
Sales Y/Y36.06%
EPS Q/Q32.84%
Sales Q/Q45.59%
Sales Surprise2.81%
EPS Surprise-5.84%
ATR(14)0.64
Perf Week1.02%
Perf Month8.70%
Perf Quarter6.65%
Perf Year20.61%
Perf YTD6.65%
Target Price31.62

AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer